🔎 Trials Near Me

Akèy › Kasinòm epitelyal ovè › North Carolina › Durham

Etid klinik pou Kasinòm epitelyal ovè nan Durham, NC

8 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan ak bò kote Durham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • UNC- Chapel Hill, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Ap rekriteFaz 3
  • Research Site, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Fanm · Mizajou Jul 21, 2026 · NCT07218809

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Ap rekriteFaz 3
  • UNC Hospital, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Fanm · Mizajou Jul 2, 2026 · NCT06819007

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

Ap rekriteFaz 1
  • Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Fanm · Mizajou May 19, 2026 · NCT06305299

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

Ap rekriteFaz 1
  • Site 0259, Durham
Laj 18 ak plis · Fanm · Mizajou Apr 7, 2026 · NCT04516447

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Ap rekriteFaz 2
  • Duke Cancer Center, Durham
Laj 18 ak plis · Fanm · Mizajou Dec 23, 2025 · NCT06690775

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of North Carolina, Chapel Hill · 10 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Kasinòm epitelyal ovè nan lòt vil

Lòt etid nan Durham

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.